Products

GlucoSense
GlucoSense
Endocrinology & Metabolic AI
GlucoSense is an AI-powered CGM intelligence platform that provides personalized insights for individuals with diabetes and tools for population health management for healthcare providers and health plans. It integrates with various CGMs and wearables to offer real-time monitoring, AI-driven food logging, and simplified care team workflows.

See all 1 product →

About GlucoSense

GlucoSense is a digital health company that leverages AI to transform diabetes management for individuals, health plans, and care teams. The company’s platform integrates data from continuous glucose monitors (CGMs), insulin pumps, and fitness trackers to provide personalized insights and simplify workflows. For patients, GlucoSense offers a personalized companion that translates CGM and lifestyle data into clear, meaningful insights, helping them understand how factors like meals, sleep, and activity affect their glucose levels. Key features for individuals include daily, weekly, and monthly reflections, an AI chat companion, AI-driven food logging, and a “GlucoScore” that provides a quick snapshot of daily glucose management.

For healthcare providers and health plans, GlucoSense offers tools to monitor diabetes populations in real-time, streamline care coordination, and deliver personalized daily support at scale. The platform translates device data into structured intelligence, providing continuous population visibility and personalized member engagement through an AI-powered companion. Care managers receive concise, one-page summaries of member data, rather than extensive raw data, to facilitate more efficient and informed conversations. GlucoSense aims to address the challenges of diabetes care, such as provider shortages and the burden of daily management on patients, by providing proactive and connected care.

Focus Areas

AI-driven diabetes management continuous glucose monitoring (CGM) data analysis personalized health insights digital health population health remote patient monitoring

Business Intelligence

Key InvestorsTech Alpharetta, CREATE-X, Advanced Technology Development Center, GTF Ventures
PartnershipsDexcom, Mayo Clinic, Pumps On Cue
Acquisitionsunknown
TechnologyCloud-native, AI-powered platform integrating data from CGMs, insulin pumps, and wearables; proprietary GlucoScore™ algorithm; LiveCore™ for real-time communication and interactive learning (GlucoSense Digital Corporation)
FDA Clearances1 (Breakthrough Device Designation) cleared products (estimated)

What Physicians Need to Know

AI-Driven Diabetes Management
GlucoSense utilizes AI and machine learning to analyze continuous glucose monitoring (CGM) data alongside lifestyle factors like sleep, fitness, and insulin. It provides personalized insights and predictions to help users understand how their daily choices impact blood sugar levels.
Continuous Glucose Monitoring (CGM) Data Analysis
The platform seamlessly integrates data from existing CGMs, insulin pumps, and fitness trackers, consolidating scattered information into a single, comprehensive view.
Personalized Health Insights
GlucoSense translates complex data into clear, meaningful insights and actionable feedback. It offers 'Daily Insights' and 'Weekly & Monthly Insights' to highlight trends, progress, and areas for adjustment.
Digital Health & Remote Patient Monitoring
The GlucoSense app acts as a personalized diabetes companion, delivering insights and nudges to users. It also provides streamlined workflows and one-page summaries for care teams, enabling continuous population visibility and personalized member engagement without adding clinical headcount.
Population Health Management
For health plans and systems, GlucoSense offers real-time monitoring of diabetes populations, identifies members needing support, and facilitates proactive, personalized interventions at scale.
Key Differentiator: GlucoScore
A standout feature is the GlucoScore, an easy-to-understand rating from 1 to 10 that provides a quick snapshot of daily glucose management and historical trends. This simplifies complex glucose data for both users and their care teams.
Key Differentiator: Device Agnostic & Less Logging
GlucoSense is device-agnostic, connecting with various CGMs and wearable devices. It also minimizes manual logging, operating largely in the background to provide insights without added user effort.
Technology Stack
Built by AI researchers and engineers from Georgia Tech, GlucoSense leverages custom-built artificial intelligence and machine learning algorithms to predict how a user's body will react to various factors.
Physician Tip

GlucoSense provides physicians with a 'Provider Portal' that transforms fragmented lifestyle data into a complete picture of their patients' health. It offers continuous population visibility, allowing care teams to see who is improving and who needs support. Physicians receive one-page summaries with key findings and conversation guidance, rather than overwhelming raw data, enabling more informed and productive conversations during appointments and empowering patients between visits. The GlucoScore and personalized insights help bridge the gap in understanding complex glucose patterns, making it easier to communicate with patients and tailor treatment plans.

GlucoSense is designed to be device-agnostic, seamlessly integrating with existing Continuous Glucose Monitors (CGMs), insulin pumps, and various fitness trackers.

Products by GlucoSense

1 product in the directory

GlucoSense
GlucoSense
Endocrinology & Metabolic AI
GlucoSense is an AI-powered CGM intelligence platform that provides personalized insights for individuals with diabetes and tools for population health management for healthcare providers and health plans. It integrates with various CGMs and wearables to offer real-time monitoring, AI-driven food logging, and simplified care team workflows.

Reviews & Opinions

No web reviews on file yet for GlucoSense. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about GlucoSense.

Loading videos...

Videos load interactively. If none appear, search YouTube for GlucoSense →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

GlucoSense utilizes AI and machine learning algorithms to analyze continuous glucose monitoring (CGM) data, identifying patterns and predicting glycemic trends that might be missed by manual review. This enables personalized insights and proactive recommendations for patients and clinicians, aiming to optimize treatment strategies and improve glycemic control.
GlucoSense analyzes a comprehensive range of CGM data, including glucose levels, trends, variability, and time-in-range metrics. For individual patients, this translates into personalized dietary, activity, and medication recommendations. For population health, aggregated and anonymized data can identify high-risk patient cohorts, assess intervention effectiveness, and inform targeted public health strategies.
GlucoSense offers a digital health platform that integrates with various CGM devices, providing a secure portal for data visualization and analysis. The platform is designed to integrate with existing EHR systems to minimize physician workflow disruption. Patient compliance is addressed through user-friendly interfaces, educational resources, and personalized nudges to encourage engagement.
GlucoSense offers flexible pricing models, including per-patient subscriptions and tiered pricing for larger health systems, with options for bundled services. Our support model includes dedicated account management, technical assistance, and clinical support to ensure seamless integration and optimal utilization of our platform.
GlucoSense has established partnerships with leading CGM manufacturers to ensure broad device compatibility and data integration. We are also exploring collaborations with pharmaceutical companies for integrated therapeutic solutions and with other digital health platforms to expand our ecosystem. GlucoSense is a well-funded company with a clear long-term vision to be a leader in AI-driven diabetes management, continuously innovating to improve patient outcomes and reduce healthcare costs.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.